Results 1 to 10 of about 8,230,812 (271)

Principal predictors of major adverse limb events in diabetic peripheral artery disease: A narrative review [PDF]

Atherosclerosis Plus, 2021
Background and aims: The increasing prevalence of diabetes mellitus is causing a massive growth of peripheral artery disease incidences, a disabling complication of diabetic atherosclerosis, which leads often to the amputation of the affected limb ...
Federico Biscetti, Andrea Leonardo Cecchini, Maria Margherita Rando, Elisabetta Nardella, Antonio Gasbarrini, Massimo Massetti, Andrea Flex   +6 more
doaj   +8 more sources

Predictors for the Development of Major Adverse Limb Events after Percutaneous Revascularization—Gender-Related Characteristics [PDF]

Medicina, 2023
Background and Objectives: Revascularization has been proven to be superior to medication for symptom improvement in patients with peripheral arterial disease (PAD). There are well known gender differences in therapeutic strategies for PAD. The influence
Horatiu Comsa, Gabriel Gusetu, Gabriel Cismaru, Bogdan Caloian, Radu Rosu, Dumitru Zdrenghea, Adina David, Bogdan Dutu, Raluca Tomoaia, Florina Fringu, Diana Irimie, Dana Pop   +11 more
doaj   +7 more sources

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants [PDF]

Cardiovascular Diabetology, 2020
Background Evidence of adverse clinical outcomes for non-vitamin K antagonist oral anticoagulant (NOACs) and warfarin in patients with atrial fibrillation (AF) and diabetes mellitus are limited.
Yi-Hsin Chan, Hsin-Fu Lee, Pei-Ru Li, Jia-Rou Liu, Tze-Fan Chao, Lung-Sheng Wu, Shang-Hung Chang, Yung-Hsin Yeh, Chi-Tai Kuo, Lai-Chu See, Gregory Y. H. Lip   +10 more
doaj   +3 more sources

Microbiota γ‐Butyrobetaine Is Associated With Increased Risk of Major Adverse Limb Events in People With Lower Extremity Arterial Disease Undergoing Endovascular Therapy [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Peripheral artery disease (PAD), a significant contributor to both acute and chronic illnesses, indicates a grave prognosis, but it is often unrecognized and receives inadequate treatment.
Zheng‐Wei Chen, Wei‐Kai Wu, Jiun‐Yang Chiang, Nai‐Chen Cheng, Jen‐Kuang Lee, Ming‐Shiang Wu   +5 more
doaj   +4 more sources

Von Willebrand Factor and ADAMTS13 in Relation to Major Adverse Limb Events in Peripheral Artery Disease [PDF]

Vascular Specialist International
Purpose: This study aimed to investigate the relationship between the two biomarkers, von Willebrand factor (VWF) and ADAMTS13, and major adverse limb events (MALE) in patients with peripheral artery disease (PAD). Materials and Methods : After obtaining
Noa Agid, Peter Andrisani, Hamzah Khan, Mohammad Qadura, Colin A. Kretz, Vinai C. Bhagirath   +5 more
doaj   +4 more sources

Hospital Readmissions Following Endovascular Therapy for Critical Limb Ischemia: Associations With Wound Healing, Major Adverse Limb Events, and Mortality [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundThe significance of hospital readmission after endovascular therapy for critical limb ischemia (CLI) is not well established. We sought to investigate the incidence, timing, and causes of readmissions after endovascular therapy for CLI and ...
Grant W. Reed, Pejman Raeisi‐Giglou, Rami Kafa, Umair Malik, Negar Salehi, Mehdi H. Shishehbor   +5 more
doaj   +4 more sources

Long‐Term Visit‐to‐Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Peripheral arterial disease (PAD) is a severe complication in patients with type 2 diabetes. Glycemic variability (GV) is associated with increased risks of developing microvascular and macrovascular diseases. However, few studies have focused
Jung‐Chi Hsu, Yen‐Yun Yang, Shu‐Lin Chuang, Kuan‐Chih Huang, Jen‐Kuang Lee, Lian‐Yu Lin   +5 more
doaj   +3 more sources

Balancing Days at Home and Major Adverse Limb Events After Surgical Versus Endovascular Lower‐Extremity Revascularization in Chronic Kidney Disease [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The risk–benefit trade‐offs after lower‐extremity revascularization among older patients with chronic kidney disease remain unclear. We compared how surgical versus endovascular lower‐extremity revascularization associates with clinical ...
Tara I. Chang, Gomathy Parvathinathan, Sai Liu, Jun Young Lee, Ali Etemadi, Shipra Arya, Margaret R. Stedman   +6 more
doaj   +2 more sources

Impact of comorbid depression on clinical outcomes in patients with peripheral artery disease: a systematic review and meta-analysis [PDF]

Frontiers in Cardiovascular Medicine
BackgroundDepression is a common comorbidity in cardiovascular disease; however, its prognostic impact in peripheral artery disease (PAD) remains uncertain.
Chuwen Chen, Lijia Wei, Jing Hu, Huanrui Hu, Bin Huang, Jichun Zhao, Wayne W. Zhang, Wayne W. Zhang, Wayne W. Zhang, Xiyang Chen   +9 more
doaj   +2 more sources

Association of Lipoprotein(a) With Major Adverse Limb Events and All‐Cause Mortality Following Revascularization for Chronic Limb‐Threatening Ischemia: A Substudy of the BEST‐CLI Trial [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The BEST‐CLI (Best Endovascular Versus Best Surgical Therapy in Patients With Critical Limb Ischemia) trial tested the optimal initial revascularization strategy in patients with chronic limb‐threatening ischemia.
Alexander E. Sullivan, Shi Huang, Suman Kundu, Victoria E. Thomas, Daniel G. Clair, Aaron W. Aday, Matthew T. Menard, Alik Farber, Kenneth Rosenfield, Jonathan D. Newman, Jeffrey S. Berger, Quinn S. Wells, Matthew S. Freiberg, MacRae F. Linton, Joshua A. Beckman   +14 more
doaj   +2 more sources